tackle The National Federation of Prostate Cancer Support Groups Report of 01ctorS and Financial statements for period ending 315t December 2024 prostate cancer THE NATIONAL FEDERATION OF PROSTATE CANCER SUPPORT GROUPS REPORT OF DIRECTORS AND FINANCIAL STATEMENTS FOR THE PERIOD ENDING 31ST DECEMBER 2024 Reglstered Charlty No (England & Wales): 1163152 A company limited by guarantee. Registered in England & Wales: 9672970 Registered oifice: Todmorden College, Burnley Road, Todmorden, OL14 7BX
The National Federation of Prostate Cancer Support Groups Report of Directors and Financial statements for period ending 31st December 2024
Board of Directors
List of all Directors serving in 2024:
Stephen Allen Appointed February 2022, Resigned June 2024 Aidan Adkins, Appointed February 2022, Resigned June 2024 Frank Chinegwundoh MBE Appointed February 2022 Anthony Collier BEM Appointed March 2023 Peter Corbishley Appointed March 2023 Angela Jones, Finance Director Appointed December 2022 Kyriakos Mastris Appointed March 2023 Roshani Perera, Chair Appointed March 2020 Shievon Smith Appointed September 2024 Joseph Hill Appointed September 2024 Paul Davies Appointed June 2024 Gary Eloket Appointed June 2024 Dave Wardell Appointed June 2024
Charity Registration Number 1163152 Company Registration Number 9672970
Registered Office
Todmorden College, Burnley Road, Todmorden, OL14 7BX
Independent Examiners
TGFP Fulford House Newbold Terrace Leamington Spa CV32 4EA
Bankers
Nat West Liverpool Street Station (B) Branch, PO Box 282, Bishopsgate, London EC2M 4QB
2
tackle The National Federation of Prostate Cancer Support Groups Report of Directors and Financial ststements for period ending 31st December 2024 prostate cancer The Trustees are pleased to present th8ir annual directors, report togeth8r with the financial statements of the charity for the year ended 31 December 2024 whiGh are also prepared to meet the requirem8nts for a directors. report and accounts for Companies Act purposes. The financial statements follow th8 Charities Act 2011. the Companies Act 2006. the charity's Memorandum and Articles of Association, and the Statement of Recommended Practice- Accounting and Reporting by Charities appli¢able to charitl8s preparing their a¢¢ounts by the Financial Reporting Standard applicable in the UK and Ireland (FRS 102) (effective 1 January 2015). STRUCTURE, GOVERNANCE AND MANAGEMENT Governing Document The National Federation of Prostste Cancer Support Groups (operating under the name: Tackle Prostate Cancer) is a charitable company limited by guarantee. incorporated on 6 July 2015, and registered as a charity on 14 August 2015. On 1 January 2016. Th& National Federation of Prostate Cancer Support Groups acquired the whole of the assels and liabilities of the unincorporated association Prostate Cancer Support Federation (PCSF). PCSF had been fomied in September 2007 and was dissolved in February 2016. The company was set up under a Memorandum and Articles of Association (Articles) which set up the objects, powers, and governance of the company. These Articles wer8 r8vised and adopted by special resolution on 6 February 2023. Re¢ruitmont, induction, and training of Directors (Trustees) The Board consists of not less than three nor more than ten Directors made up as follows.. Up to seven Directors being members of member organisations and el8Ct8d by the members at the Annual General Meeting Up to three Directors appointed by the Board who have a specifiG expertise e.g.. finance, HR or marketing.. and The Directors shall appoint one of their number as Chair and may detemiine the length of lerm to serve in that office. The Directors may also appoint one of thoir number as vic8-chair. Directors are also Trustees of th8 charity and govem the activities of the Charity as a Board. Upon appointment lo the Board. to help ease their understanding of the current issues concerning the organisation, each new Director is provided with a copy of the Charity Commission publication entilled 'The Essential Trustee-. What you need to know" which gives guidance on what is expected of them. New Directors are also provided with briefings from the Chair on th8 Structure. strategy and operations of the charity. The Board meets four times a year army devolves responsibility for overseeing the day-to-day running of the organisation to the executive team curr8ntly led by Sarah Gray and overseen by the Chair and Vice-chair. Sub-committees with Trustee representation is in pla to govern specific adivities such as fundraising, marketing. appointments and remuneration. The purpose of the charlty The charity is a federalion, whose member organisations (-members") are patient-led prostate canr support groups. The purpose of the charity is to c¢>ordinate, fo¢us and
tackle The National Federation of Pr95tate Cancer Support Groups Report of Dirertors and Financial statements for period ending 31st December 2024 prostate cancer Objectivos arKI activities for the public benefit As sel out in its governing document. the objects of the charity are to relieve the sickness. physical and mental distress of persons affected by prostste cancer in th8 UK. but not exclusively by.. assisting and strengthening the activtties in support of people affected by prostate cancer. including encouraging and supporting the formation of new local prostate support organisations throughout the UK encouraging the improvement of health services available to prostate ¢anor patients; and acting as a focus for and expr8ssing the views of patient-led support groups conceming a. raising awareness of prostste canr improving the health services available to prostate cancer patients., and c. priorities for research into the diagnosis and treatment of prostste nCer. Our vision is to be the 'go to, d)arity for peer support and our mission is To enable th6 growth of peer support groups across the country. ensuring the n88ds of people living with and impacted by proslate cancer are met, and their voices are heard. Our strategic imperatives as sel out in our 3-year plan (2023-20261 are to: Grow and strengthen our relationships and repulation amongst peer support group$ Recognise and amplify the importan¢e of tha usar voico across tho health and social care system Demonstrate our impact and value to the prostate cancer communty and general public Secure financial sustainability through an effective fundraising strategy Ensure we have robust organisational governance to deliver our strategy and mandatory requirements Achievements In 2024 We continued our mission to become the 'go to, charity for peer support by investing in th8 people who lead our groups. This year, we launched Best Practice Guidelines, built a more user-friendly Members, Portal. and mainlained a sleady rhythm of monthly briefings. Zoom meetings. and in-person visits to support our leaders. We delivered 30 face-to-face group visits and facilitated regular group leader forums attended by an averag8 of 35 leaders per session. More than 60% of 8UPPOrt groups now use the Members, Portal. We are working to encourage and support the take up of our Best Practice Guidance. which was launched in April 2024- a sel of principles to ensure good g0veMan of our member support groups. Recognising the powerful influence of real-life stories, we launched the 'Many FaS of Prostate Cancer, campaign, a follow-up to the successful 'L8t's Talk About IY series. These short films aim to share the real-life experieeS of people from diverse backgrounds and communf(ies.
tackle The National Federation of Prostate Cancer Support Groups Report of Directors and Financial statements for period ending 31st December 2024 prostate cancer We also scaled up our digital engagement. Website visitors grew by 44%, and social media engagement rose by over 90¥0. Working in partnership with other charities in the cancer community. Tackle has remained at the forefront of national campaigns. As partners in campaigns suth as Boys Need Bins, our supporters advocated for changes in their localities, including the installalion of sanitary bins in male cubicles across Lancashire and Herefordshiré. We are working in partn8rship with Prostate Cancer Research and others to advocate for target8d scre8ning for high-risk eK)mmunities through the Proactive for your Prostate campaign. Members of our board and staff have been active in lobbying MPS at iwo Palace of Westminster events. We continue lo lobby for better diagnosis, treatment. and services as part of The One Cancer Voice campaign. 2024 saw the launch of 7 new groups. bringing our n81work to 140. We introduced groups in underserved areas and activily-based models. The Peer Coaohing Programme, now funded by Movember, began its rollout with the first'Train the Trainerf s6ssions. We also ernbedded equity, diversity. and inclusion principles through new partnerships and ongoing training Looking Ahead We have built strong foundations with our National Lottery and Movember funded projects. and our upcoming work will focus on: Expanding and piloting the Peer Coaching model Growing our network of groups in Yorkshire and the Northeast and across the Midlands, wlth a particular focus on ensuring we meet the needs of underserved communities. Growing our community fundraising Ensuring our nelwork of Group Leaders and organisers have the tools, krtowledge, and skills to run welcoming. effective, safe and well-governed support groups and Participate in national campaigns.
tackle The National Federation of Prostate Cancer Support Groups Report of Dirertors and Financial statements for period ending 31st December 2024 prostate cancer FINANCIAL REVIEW Flnancial Perforniance Our income this year at £179,228 was an incr88se of 459h on 2023. Our expenditure of £201,790 was up by 31°k overall, with charitable expenditure increased by 24°/o. W8 finished the year with a deficit of £22,561. As recognised by the Board in their risk assessment, fundraising contlnu8S to b8 a serious challenge for the Charity. We are extremely grateful to all our members and supporters for their generosity in donating funds to COV8r th8 work that we do to support prostate cancer patienls and their families. In line with ABPI guidelines, we continued to benefit from financial support from phamiaceutical companies, some of whom we work closely with as patient advocates. Reserves Policy In line with the guidance issued by the Charity Commission. the Trustees have considered the future n8eds of the charity and believe that unrestricted general funds, that is funds which are neither restricted nor desnated, should be at least three months, forward operating expenditure. Such funds are needed to safeguard the charity's aGtivity against an unexpected shortfall in fundraising income, emergency, or unforeseen expenditure and to ensure its financial slability over the longer term. Statement of Trustees. Responsibilities The Trustees (who are also the Directors of th8 charitable company for th8 purposes of company law) handle preparing the Annual Report and financial statements following applicable laws and United Kingdom Generally Accepted Accounting Practice. Company law requires the charity trustees to pr8pare financial statements for each year which give a true and fair view of the situation of the charitable company and of the incoming re$our¢es and appli¢ation of resources induding the income and expenditure of the charitable company for Ihat pericd. In preparing those financial statefflents, the ttustees must.. select suitable accounting policies and then apply them consistentty. observe the methods and principles in the Charity SORP 2015 (FRS 102). make judgements and estimates that are reasonable and prudent. state whether applicable accounting standards have been followed; and prepare the financial statements on the going concem basis unless it Inappropriate to presume that the chariiable wmpany will continue in business. The trustees handle keeping prop6r accounting records which show with reasonable accuracy at any time the financial position of the charitable company and to enable them to ensure that the financial statements follow the Companies Act 2006. Th8y are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevenkn'on and detection of fraud and other irregularities. The trustees handle the maintenance and integrity of the corporate and financial information included on the tharitable company website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
tackle The National Federation of Prostate Cancer Support Groups Report of Direttors and Financial statements for period ending 31st DeMber2O24 prostate cancer This report was approv8d by the Board of Trustees and signed on its behalf by: Roshani Perera Roshani Perera
The National Federation of ProS&e Cancer Support Groups (operating as Tacklo Prostate Cancer) Independent Examinerfs Report to the Trustees of The National Federation of Proststs Cancer Support Groups I report lo the charity trustees on rny examination of the accounts of the company for Ihe year ended 31 December 2024. which are set out on pages 10 to 17. Rosponsibilities and basis of report As the charity trusteés of the company land also its directors for the purposes of company law) you are responsible for the preparation of the accounts in a¢cordanc8 with the requirements of the Companies Act 2006 ('the 2006 Act.). Having satisfied myself thal the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination. I report in respect of my examination of your company's accounts as carried out under section 145 of the Charities Act 2011 ('the 2011 Aot,). In carrying out my examination I have folbwed the Directions given by the Charity Commission under section 145(5){b) of the 2011 Act. Basis of independent examinefs report My examination was carried out Sn accordance wlth the general Directions given by thè Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts and seeking explanations from you as trustees cOnrning any such matters. The procedures undertaken do not provid8 all the evidenGe that would be required in an audit and consequentjy no opinion is given as lo whelher the accounts presènt a 'tru8 and fair view, and the report is limited to those matters set out in the statemgnt below. Indepond8nt examiner's statement I confimi that l am qualified to und8rtak8 the examination because l am a member of Ihè Institute of Chartered Accountants in England and Wales. I have completed my examination. I confimi that no matters have come to my attèntion in connection with the examination giving me cause to believe that In any mat8rial r8SP6Ct'. accounting records were not kept in respect of the company as required by sectlon 386 of the 2006 Act., or 2. the accounts do not accord with those records., or 3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair view, which is not a matter considered as part of an independent examination., or 4. the accounts have not been prepared in accordan with the methods and principles of the ststement of Recommended Pra¢tice for accounting and reporting by charities {applicabl8 to charities preparing their accounts in accordan with the Financial Reporting Standard applicable in the UK and Republic of Ireland {FRS 102)-
Tho National Federation of Prostatè Cancer Support Groups (operating as Tackle Prostate Cancer) Independent Examiner's Report to the Trustees of Tho National Fèderation of Prostate Cancer Support Groups - continuod I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of th8 accounts to be reached. BENJAMIN R REYNOLDS Bsc (Hons) FCA. TGFP Chartered Accountants & Statutory Auditors Fulford House Newbold Terrace Leamington Spa CV32 4EA Date: 2310412025
The National Federation of Prostate Cancer Support Groups (operatlng as Tackle Prostate Cancèr) Statement of Financlal Activities for the year ended 31 December 2024 INCOME AND EXPENDITURE Unreslrictsd Funds Restricted Funds Tolal 2024 Total 2023 Note Incomlng Rosour¢&s Voluntary income Investment income 76,255 595 102.378 178.633 595 122.7C 667 Total Income 76.850 102,378 179,228 123,367 Expondlturé on: Raising funds Charitable activities 25.049 90,071 103 86,566 25.152 176,637 11.867 142,469 Totsl Expenditure 115,120 86,669 201,789 154,336 Net Incomel{Expondilure) (38.270) 15.709 (22.561) (30,969) Net Movement In Funds for tho Year 38.270) 15.709 (22,561) 30,9) Reconciliation of Funds Total funds blf at 1 Jan 2024 115,035 49,057 164.092 195,060 Funds Transfer 7.269 (7.269) Totsl fund5 Gtt at 31 t)ec 2024 10 The statemenl of finan¢ial adivitie5 inGludes all gains and losse5 recognised in tho year. All income and expenditure deriv85 from continuing activities. Pag8= 10
The National Federation of Prostate Cancer Support Groups (operating as Tackle Prostate Cancer) Statement of Net Assets As At December 2024
| Note Fixed Assets Current Assets Debtors 7 Cash at bank and in hand Creditors: Amounts falling due within one year 8 Net Current Assets Net Assets Represented by: Restricted Funds 10 General Unrestricted Funds 10 Designated Funds 10 Total Funds |
2024 £ - 20,155 214,560 234,715 93,184 141,531 141,531 57,497 59,034 25,000 84,034 141,531 |
2023 £ - 11,865 157,848 |
|---|---|---|
| 169,713 5,621 |
||
| 164,092 | ||
| 164,092 | ||
| 49,057 90,035 25,000 |
||
| 115,035 164,092 |
The notes on pages 15 to 21 form part of these financial statements.
The charitable company is entitled to exemption under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.
The directors have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for:
-
(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
-
(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to the financial statements, so far as applicable to the charitable company.
These financial statements have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to charitable small companies. The financial statements were approved by the Board on …......1st July 2025 and signed on its behalf by:
Roshani Perera
Anthony F C Collier
Chamintha Roshani Perera Chairman
Anthony Collier BEM Finance Director
Page: 11
The National Federation of Prostate Cancer Support Groups (operating as Tackle Prostate Cancer) Note to the Financial Statements (Cont.) for tha year ended 31 December 2024 Accountlng Policies (continued) Operating l•as•s Rentals payable under operating leases are charged against income on a straight line basis over the18as8 term. g. Financial Instruments Basic financial assets, which include cash and bank balans, are initially measured at transaction price including transaction costs and are subsequenlly carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction. where the transaction is measured at th8 pr8sent value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. h. Funds General lunds - thesè are unrestricted funds which can be used for the charitable objects at th6 discretion of the Trustees and which have not been designated for other purposes. Rèstrict8d funds - these are funés that Can only be used for particular restricted purpos8S Wlthin the objects of the charity- Restrictions arise when speGified by the donor or when funds are raised for particular restricted purpos8s. The aim and use of each restricted fund is set out in the not6s to the financial statements. Deslgnated funds - these are UnstriCted funds which have been set aside by th8 Trustees for specific purposes. The aim and use of 6ach designated fund is set out in the notes to the financial statements. Interest recelvable Interest on funds held on deposit is included when receivable- this is nomally upon receipt or upon notification of the interest paid by the Bank or Building Society. P8nsion costs The Charity operates a defined contribution stakeholder pension scheme. The amount charged to the statemenl of financial activities in respect of pension costs is the Charity's contributions payable in the year. The assèts of th8 scheme are held separately from the Charity. There was no outstanding liability owed to the scheme at the end of the currenl or prior years. k. Employee Benefits The cost of short-term employee benefits are recognised as a liability and an expense. The cost of any material unused holiday entitlement is recognised in the period in which the employee's seNices are received. Page.. 12
The National Federation of Prostate Cancer Support Groups (operating as Tackle Prostate Cancer) Note to the Financial Statements (Cont.) for the year ended 31 December 2024 2 Voluntsry Income Unrestricted 2024 Restricted 2024 Total 2024 Total 2023 Donations received from.. Members Individuals and Community Trusts and Foundations Companies 13,307 32,718 30.230 13,307 135,096 30.230 10,717 73.583 38.400 102,378 102,378 178 633 122.700 Of which in 2023: Unrestricted Restricted 74.067 48.633 122.700 For a breakdown of prior year comparatives. see not8 12 3 Fundraislng Activities Unrestricted 2024 Restricted 2024 Total 2024 Total 2023 Fundraising Costs Support Costs Govemance Costs 25.049 103 25,152 11,867 103 25,152 11,867 Of whlch In 2023: Unrestricted Restricted 11,867 For a breakdown of prior year comparatives. see note 12 4 Charitable Activities Note Unrestricted 2024 Restricted 2024 Total 2024 Tolal 2023 Campaigning & Awareness Groups Support Staff Costs Support Costs Govemance Costs 14,487 4,352 33,020 21.330 16,882 6,343 6,274 48,571 17.704 7,674 20,830 10,626 81,591 39,034 24,556 19,938 23,728 63,657 29,371 15,775 90,071 86,566 176 637 142,469 Of which in 2023: Unrestricted Restricted 54,701 87,768 142 469 For a breakdown of prior year comparatlV8S. See note 12 Page: 13
The National Federation of Prostate Cancer Support Groups (operating as Tackle Prostate Cancer) Notes to the Flnancial Statements (Cont.) for the year ended 31 December 2024 5 Support and Governance Costs Support Govarnance Costs Costs Total 2024 Total 2023 other Costs Bank Charges Trustee Meetings and Expenses Audit Legal & Professional Fees 37,780 58 1.196 23,801 61,581 58 1.479 40.853 72 3.488 283 472 472 733 39.034 24.556 45,146 Basls of AllotIOn 0.00 100.0°/ Allocated to fundraising costs AlloGated to Gharitablg activitles 39.034 24.556 63,590 100.00 6 Staff Costs 2024 2023 Salaries and wages Social security costs Pension contributions Recruitment Training 71060 2.570 1,759 1.202 52.481 310 429 438 Total 8mploy88 cosls 53,658 No employee eamed in excess of £60,000 p.a. The key management personnel of the Charity are the Trustees who do not receive remuneration but during the year the charity paid aggregale expenses tolalling £1,479 (2023.. £3,488) relating to 512023.. 9) trustees in respect of travel, accommodation and subsistence. The charity includes Trustees. Liability Insuran in its combined Insuran policy. The average number of employees (headcount based on number of staff employed) during the year was as follows.. 2024 2023 Engagement 7 Debtors 2024 2023 Other debtors Prepayments 15,289 4,866 11.250 615 11,865 Page.. 14
The National Federation of Prostate Cancer Support Groups {operating as Tackle Prostate Cancer) Notes to the Financial Statements (Cont.) for the year ended 31 December 2024 8 Creditors: amounts falling due within onè ar 2024 2023 Trade creditOT5 Taxation and Social Security Accruals other Credltors Deferred Income 5409 1,828 2.632 1,028 133 1028 133 81927 9 Analysis of Net As$ets between Funds Unrestricted Restricted Funds Funds Total Funds Total assets Current liabilities Net Assets at 31 Dec 2024 177,218 93,184 57,497 234,715 193,184) 141 531 For a breakdown of prior year compardtives, se8 note 12 10 Movements In Funds 1Jan Incomlng 2024 Resources Outgoing Resources Fund Transfers 31 Dec 2024 Unrestricted Funds: General Designated - Development Fund 90,035 25,000 76.850 (115,120) 7,269 59,034 25,000 Total Unrestricted Funds 115,035 76,850 (115.120) 7,269 84,034 Re8trlctod Funds: Tackle Man Van National Lottery Community Fund Tackling Prostate Cancer- peer to peer suppcvl for m6n wolh prost8te cancer Other restricted funds 2,500 12,500) 14.596 31,961 95.378 7,0(Kl (62,033) (24,636) 47,941 9,556 {4.7691 Tolal Restricted Funds 49.057 102,378 86,669 {7.2691 57,497 Total Funds 164,092 179,228 201,789 141.531 For a breakdown of prior year comparatives, see note 12 Pagg.. 15
The National Federation of Prostate Cancer Support Groups (operating as Tackle Prostate Cancer) Notes to the Financial Statements {Cont.) for the year ended 31 December 2024 12 Comparative Nots Only Not8 2 - Voluntary Income 2023 Total Unrestricted Restricted Donations rnceived from." Members Individuals and Community TNsts and Foundations Companies 10,717 24,950 38,400 10,717 73,583 38,400 48.633 74,067 48,633 122.700 Note 3 - Fundraising Activities 2023 Total Unrestricted Restricted Fundraising Costs Support Costs Govemance Costs 11.867 11,867 Note 4 - Charitable Activities 2023 Total Unrestricted Restricted Campaigning & Awareness Groups Support Staff Costs Support Costs Govemance Costs 13,236 3.153 6.003 17,126 15,183 6,702 20.575 47.654 12.245 592 19,938 23,728 53,657 29,371 15,775 54,701 87.768 142 469 Note 9 - Analysis of N•t Assets between Funds Unrestrlcted Funds 2023 Total Funds Restrlcted Funds Total assels Current liabilities Net Assets at 31 Dec 2023 120,655 (5.621) 115,034 49.057 169,712 {5,621} 164,091 Page: 16
The Natlonal Federation of Prostate Cancer Support Groups (operating as Tackle Prostate Cancer) Notes to the Financial Statements (Cont.) for the year ended 31 December 2024 12 Comparatlve Note Only (Gontinued) Note 10 - Movements in Funds 1Jan Incoming Outgolng 2023 Resources Resourcès Fund Transfers 31 Dec 2023 Unreslricted Funds: General Designated - Development Fund 81,867 25,OC 74,734 166,567) 90,034 25,000 Total Unrestricted Funds 106,867 74,734 (66,567) 115,034 Restricted Funds: Ta¢kle Man Van National Lottery Community Fund Tackling Pfostale Cancer- poerto peer support for men wlh prostste cancer Other restricted funds 2,5(M) 55.936 29.757 41.633 7,000 (82,973) (4,796) 14,596 31,961 Totsl Restrlcted Funds 88,193 48.633 87,769 49,057 Total Funds 195 060 123367 154 336 Page:17